Fig. 6: Mice lacking Grik1 expression in PV interneurons are resistant to stress-induced alterations in amygdala excitability and behavior.

A Body weight changes during chronic restraint stress (CRS) protocol (Grik1fl/fl: control nā=ā17, CRS nā=ā19; RM ANOVA, F (1, 34)ā=ā21.32, ****pā<ā0.0001; PV-Cre::Grik1fl/fl: control nā=ā19, CRS nā=ā17; RM ANOVA; F (1, 34)ā=ā23.89, ****pā<ā0.0001). B Action potential frequencies in response to depolarizing current steps recorded from brain slices of control and CRS-treated, Grik1fl/fl or PV-Cre::Grik1fl/fl mice (Grik1fl/fl: control, nā=ā25 (7 mice), CRS, nā=ā17 (6 mice), RM ANOVA, F (1, 40)ā=ā4.775, *pā=ā0.035; PV-Cre::Grik1fl/fl: control, nā=ā19 (6 mice), CRS, nā=ā14 (4 mice), RM ANOVA, F (1, 31)ā=ā0.0001180, pā=ā0.99). C Tonic GABAB currents recorded from LA PNs in slices from control and CRS-treated, Grik1fl/fl or PV-Cre::Grik1fl/fl mice. All recordings were done at ā50āmV holding potential in the presence of 50āμM of D-AP5, 200āμM picrotoxin, and 50āμM GYKI 53655 to block NMDA, GABAA, and AMPA receptors, respectively. The amplitude of the tonic current was measured as a change in the holding current in response to the application of 10āμM CGP55845. The graph illustrates averaged data on the amplitude of the tonic GABAB currents under various conditions (Grik1fl/fl: control, nā=ā15 (5 mice), CRS, nā=ā11 (3 mice); PV-Cre::Grik1fl/fl: control, nā=ā15 (4 mice), CRS, nā=ā18 (3 mice); two-way ANOVA for genotype and condition, genotype effect F(1,54)ā=ā19.93, ****pā<ā0.0001; post-hoc comparison *** pā=ā0.0003, Bonferroni). D Current clamp recordings from PV interneurons in acute slices from control and CRS-exposed PV-Cre::Grik1fl/fl mice. Example traces illustrate the response of the PV neurons to depolarizing current steps (75 and 200āpA), for control and CRS groups. Pooled data on the action potential frequencies in response to depolarizing current steps (control, nā=ā12 (3 mice), CRS, nā=ā12 (3 mice), Mixed-effects model (REML) F(1, 22)ā=ā1.157, pā=ā0.2938). E Results of open field (OF) test. The graphs show the total time spent in the center area of the open field (OF) and the center time in 5āmin bins, for control and CRS-exposed mice for the two genotypes, Grik1fl/fl and PV-Cre::Grik1fl/fl (Grik1fl/fl: control, nā=ā16, CRS, nā=ā19; PV-Cre::Grik1fl/fl: control, nā=ā19, CRS, nā=ā17). Total time in the center field: Two-way ANOVA: treatment F(1, 67)ā=ā3.086, pā=ā0.0835, genotype F(1, 67)ā=ā0.7517, pā=ā0.389, interaction F(1, 67)ā=ā4.133, pā=ā0.046. * pā=ā0.019, Holm-Sidak. Time in center zone in 5āmin bins: RM ANOVA, Grik1fl/fl: F(1, 34)ā=ā8.564, **pā=ā0.0062; PV-Cre::Grik1fl/fl : F (1, 34)ā=ā0.03320, pā=ā0.8566. Total distance traveled: 2-way ANOVA, genotype F(1,67)ā=ā31.74, ****pā<ā0.0001, treatment F(1, 67)ā=ā1.828, pā=ā0.1780, interaction F(1, 67)ā=ā1.495, pā=ā0.2442. All the data are presented as meanā±āSEM.